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ABSTRACT 
 
Should we welcome all developments in gene editing? Somatic cell gene editing would be on a par 
with conventional therapies aimed at treating particular conditions or alleviating symptoms. It would 
solely affect the individual patient treated. It could thus serve as a welcome new kind of treatment 
for cancers and blood diseases such as ß-thalassaemia. Germ-line gene editing, on the other hand, 
would have hereditary effects. This raises special concerns about medical mishaps. Medical risks are, 
however, not the only kinds of risks in the case of germ-line gene editing. Discussed here are not the 
medical risks, but the social and moral risks of germ-line-gene editing.  
 
 
Introduction 
 
Scientists at the Francis Crick Institute in London have been granted permission to edit the genomes 
of human embryos for research purposes. The permission was given on 1 February 2016 by the UK’s 
fertility treatment and embryo research regulator, the Human Fertilisation and Embryology 
Authority (HFEA). The permission makes the UK the first country in the world to officially sanction 
gene editing of human embryos.1 
 
While being the first country in the world to give a legal green light to the creation of gene-edited 
embryos, UK scientists are, however, not the first scientists in the world to embark on the creation 
of gene-edited human embryos. Chinese scientists beat them in this race. In a paper published on-
line in Protein &Cell, on 18 April 2015, Chinese scientists explained how, with the use of the recently 
developed gene editing technique called CRISPR-Cas9, they had managed to modify the gene 
responsible for ß-thalassaemia, a potentially lethal blood disorder.2  Not surprisingly, the paper 
sparked an intense debate among scientists and ethicists about the ethics and social risks of germ-
                                                          
1 The HFEA announced the news about the licence on its website on 01.02.2016 (accessed on 09.02.2016 at: 
http://guide.hfea.gov.uk/guide/ShowPDF.aspx?ID=5966).  
The Francis Crick Institute published the news on its website on 02.02.2016 (accessed on 09.02.2016 at:  
https://www.crick.ac.uk/news/science-news/2016/02/01/hfea-decision/). 
See also, Ewen Callaway, UK scientists gain licence to edit genes in human embryos, Nature News, 01.02.2016 
(accessed on 08/02/2016 at:   http://www.nature.com/news/uk-scientists-gain-licence-to-edit-genes-in-
human-embryos-1.19270?WT.mc_id=SFB_NNEWS_1508_RHBox). 
2 Puping Liang, et.al., CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes, ‘Protein and Cell’, 
2015, 6 (5), pp. 363-372. 
line gene editing, that is, the ethics and social risks of genetic modification of human eggs, sperm 
and embryos. 
   
Using abnormal embryos obtained from local fertility clinics, the Chinese scientists found that out of 
86 gene edited one-cell embryos only 28 were successfully spliced, and that only a fraction of these 
28 contained the intended genetic material. As the Chinese team pointed out, this shows that the 
CRISPR-cas9 technique is far from being fine-tuned enough for clinical use in humans. The medical 
risks of physical mishaps are too great. This is especially because in the case of germ-line gene 
editing, if the genetic modification went wrong, the adverse effects would be hereditary. That said, 
besides the medical risks of germ-line gene editing there are also significant social and moral risks. 
 
In this paper I am concentrating on the social and moral risks of germ-line gene editing. In the last 
century we witnessed draconian eugenic policies. This was not only in Nazi Germany. In North 
America and Scandinavia, people with a various conditions, including for example epilepsy, were 
forced to be sterilized. That is, policies of sterilizing people with certain conditions were imposed by 
the state. Today such practices would be considered shameful. This does not mean that eugenics is a 
thing of the past. Presently, many or most healthcare systems promote a practice of soft eugenics. I 
am referring to pre-implantation (PGD) and prenatal diagnosis with a view to avoiding births of 
children with certain adverse conditions. In many countries diagnostic prenatal tests are 
recommended if blood tests or ultrasound screening point to a foetal problem, or if the pregnant 
mother is in her late thirties or older and therefore at increased risk of having a child with a 
chromosomal abnormality, such as Down syndrome. Likewise, PGD may be recommended in 
connection with IVF when a woman or her male partner is affected by a particular hereditary 
condition. These practices constitute a soft form of negative eugenics. I say soft eugenics, because 
nobody is being coerced to have such tests. Nor is anyone forced to undergo an abortion on grounds 
of foetal abnormality. The tests are only performed on a voluntary basis. If germ-line gene editing 
were to be practised, it too would undoubtedly be practised on a voluntary basis. So practised, it 
would constitute a form of soft positive eugenics. Some governments, health authorities and many 
pregnant women or couples might welcome the development of germ-line gene editing for the 
purpose of practising a policy of soft positive eugenics. But there are good reasons for voicing 
warnings about this development.    
 
  
The Francis Crick Institute research 
  
The aim of the embryo gene editing, to which the HFEA has granted a licence, is not that of curing 
human embryos by editing faulty genes. It is solely that of undertaking research. Dr Kathy Niakan, 
who approached the HFEA for an embryo gene editing licence in September 2015, and who will be 
undertaking the research at the Francis Crick Institute, has told the media that she only wants to 
undertake basic research studying embryological development.  
 
Unlike the Chinese scientists who, to justify their destruction of human embryos, said they were 
working with non-viable embryos, Dr Niakan who specialises in embryo development will be working 
with healthy embryos, so-called left-over embryos. In other words, she will be working with embryos 
that have been donated by couples who have undergone IVF treatment. Interested in why so many 
embryos fail to develop, she hopes that her research will improve IVF success rates. She is 
particularly interested in the genes involved in early cell differentiation. That is, she is studying the 
formation of cells destined to develop into the embryo proper and of cells destined to develop into 
intra-uterine supportive tissue, such as the placenta, umbilical cord and amniotic sac.3  
                                                          
3The Francis Crick Institute published a statement about the research on its website of 02.02. 2016 (accessed 
on 07.02.2016 at: https://www.crick.ac.uk/news/science-news/2016/02/01/hfea-decision/). 
 
Since the present aim of embryo gene editing at the Francis Crick Institute is that of undertaking 
basic research, it might seem innocuous enough. It might seem so, unless you recognize the human 
embryo as a nascent member of the human family and therefore worthy of respect and protection. 
That is to say, the destruction of human embryos used in research is one reason why the research at 
the Francis Crick Institute is morally controversial. However, this is not the only controversial aspect 
of this research.  While the present aim of embryo gene editing at the Francis Crick institute is that 
of undertaking basic research, the longer-term aim of this research looks different, as witness the 
talks and discussions about the science and ethics of gene editing at the conference of the Progress 
Educational Trust, in London, on 9 December 2015. Among the speakers was Professor Robin Lovell-
Badge of the Francis Crick Institute, who expressed the view that once the CRISPR- Cas9 technique of 
gene editing has been perfected, germ-line gene editing might prove a superior alternative to 
somatic gene editing for therapeutic purposes. He said germ-line gene editing might eventually 
prove to be a safer way of eliminating faulty genes than somatic gene editing. Explaining why, he 
said that gene editing of a one-cell embryo, sperm or egg would entail less risk of off-target effects 
compared with somatic gene editing in which millions of cells are genetically modified. 4 It should be 
added that he was not the only speaker at the conference who expressed hopes about the benefits 
of germ-line gene editing.  
 
 
International Summit on Gene Editing 
 
While CRISPR-Cas9 has raised many hopes and expectations within medical and scientific 
communities, it is clear that germ-line gene editing is controversial. This is the very reason why 
scientists from all over the world convened at the International Summit on Gene Editing, jointly 
organized by the US National Academies of Sciences, the UK Royal Society and the Chinese Academy 
of Science in Washington D.C., on 3-5 December 2015.5  
 
Not surprisingly, clinical use of gene editing of somatic cells was welcomed by the participants. Used 
for somatic gene editing, gene editing techniques, such as the much celebrated CRISPR-Cas 9 
technique, would serve the purpose of curing the individual patient of a particular medical condition. 
Such treatment would, in principle, be no different from more conventional therapies inasmuch as 
the effects would only affect the individual person and thus would not be hereditary. In other words, 
somatic gene editing would constitute a new therapy complementing already existing treatments to 
heal a sick patient of a particular disease.  The committee, therefore, supported further research 
into genetic modification of, for example, blood cells in search of cures for cancers and conditions 
such as sickle-cell anaemia.  
 
Several concerns were, however, voiced about embryo gene editing, though the experts at the 
meeting did not say categorically no to it. On the contrary, they were clearly expecting germ-line 
gene editing to be used for clinical purposes in the future. Thus they only said no to the use of this 
technology for the time being. And it was decided that the debate about genetic modification of 
                                                                                                                                                                                    
See also, Ewen Callaway, UK scientists gain licence to edit genes in human embryos, Nature News, 01.02.2016 
(accessed on 07.02.2016se at:   http://www.nature.com/news/uk-scientists-gain-licence-to-edit-genes-in-
human-embryos-1.19270?WT.mc_id=SFB_NNEWS_1508_RHBox).   
4 See, Dr Jess Buxton, Genome editing and CRISPR: the science of engineering the embryo, BioNews, 18.01.2016 
(accessed on 21.032016 at: http://www.bionews.org.uk/page_606553.asp). 
5 The National Academies of Sciences, Engineering and Medicine, International Summit on Gene Editing, On 
human gene editing international summit statement, 03.12. 2015 (accessed on 06.02.2016 at: 
http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=12032015a). 
eggs, sperm and embryos for clinical purposes should be reopened periodically in the wake of 
further developments of gene editing techniques.  
 
That said, the concerns raised by the assembled scientists pointed to a number of social and moral 
issues raised by embryo gene editing, be it for the sake of eliminating diseases or in other ways 
altering the human embryo. For a start, discussing the medical risks linked to the clinical use of 
germ-line gene editing, the participants noted that, not only could things go wrong in the sense of 
adversely affecting the physical health of individual subjects, but since the effects would be 
hereditary any gene-editing mishaps could be passed on to subsequent generations. And so it was 
agreed that until gene editing techniques have been perfected their use would be immoral. At 
present the medical risks are too great.  
 
More important, it was also recognized that the risks linked to germ-line gene editing are not only 
medical. It was noted that there are social and medical risks as well. This, as observed, was because 
germ-line gene editing might in the future be used not only for therapeutic purposes but also for the 
sake of enhancement, that is, for the creation of so-called designer babies. Pointing to the possibility 
of adverse social consequences of embryo gene editing for enhancement purposes, the participants 
at the summit quite rightly said that hereditary genetic changes aimed at enhancing certain 
characteristics or abilities could exacerbate social inequalities. In other words, it could lead to a 
genetically modified over-class and social discrimination. And pointing to the possibility of unethical 
practices, they noted that germ-line gene editing for the sake of enhancement could even come to 
be used coercively. In other words, they acknowledged the risk of germ-line gene editing being 
imposed as a mandatory procedure and thus used for eugenic purposes in the future. And so they 
expressed special concern about the possibility of purposefully altering human evolution using the 
technology. They also expressed the fear that public reactions to germ-line gene editing, such as 
objections to creation of designer babies and to scientists ‘playing God’, could have the unfortunate 
effect of adversely affecting public attitudes towards somatic gene editing. 
 
 
Reflections on social and moral risks  
 
As noted, embryo gene editing, such as that undertaken purely for research purposes at the Francis 
Crick Institute, could prove to be a preamble to the perfection of genetic modification of eggs, sperm 
and embryos for clinical purposes. If the aim of clinical use of germ-line gene modification was 
purely that of correcting faulty genes, then one could admittedly see a good in it inasmuch as it 
could spare future individuals from being affected by a particular hereditary disease. Indeed, used 
for purely therapeutic purposes, germ-line gene editing serving as a tool for eliminating hereditary 
diseases that have been afflicting previous generations of particular families might be cautiously 
welcomed. I say, cautiously, because it would have to be strictly regulated. 
 
Why? Because, once permitted and used germ-line gene editing would almost certainly set in 
motion a slippery slope. While it might be argued that strict regulation could be put in place to avoid 
this, once the technology has been perfected and is in use, it might with time come to be used not 
only in order to avoid a variety of severe genetic conditions. Instead the technique could also come 
to be used in order to avoid less severe diseases. And eventually it could come to be used to 
promote or enhance certain genetic traits considered social desirable.  
 
In other words, the major concerns about germ-line gene editing are not related to the medical or 
physical risks. These risks might be overcome. The major concerns relate to the risks of adverse 
ethical and social consequences. Scientific progress made in this century has promoted an emphasis 
on children having good genes. Applicable is the warning given in the Vatican document Donum 
Vitae, of 1987, that while our new technologies ‘might constitute progress in the service of man’, 
they may also ‘expose him to the temptation to go beyond the limits of reasonable domination over 
nature’.6 What is at issue is the risk that the use of germ-line gene editing could lead to an increasing 
failure on the part of society to give the child an unconditional welcome.  
 
There is the risk that use of germ-line gene editing, like use of pre-implantation genetic diagnosis 
(PGD) and prenatal diagnosis with a view to embryo selection and selective abortion, could come to 
be widely used - at least in societies with sufficient financial resources. If used for enhancement 
purposes there is the risk, as suggested at the International Summit on Gene Editing, of adverse 
social consequences such as the creation of a genetic over-class and a genetic under-class.   
 
There is even the risk that zealous use of germ-line gene editing for the purely therapeutic purpose 
of producing perfectly healthy children could come to serve as a complement to PGD and prenatal 
testing with a view to embryo selection and selective abortion to avoid births of children with 
particular conditions. Today most countries in the world allow soft negative eugenics policies by way 
of weeding out embryos and foetuses viewed as less than perfect. Tomorrow zealous use of 
therapeutic germ-line gene editing could serve as a positive eugenic complement to these negative 
eugenic policies. The result would then be a widespread policy of soft negative-cum-positive 
eugenics of selective breeding. As such, germ-line gene therapy, like prenatal testing with a view to 
selective abortion, would come to serve as a eugenic tool. This would represent a failure to respect 
and treat the child-to-be as our equal in human dignity. The child would be treated as a product of 
human selection and making; it would be treated as a commodity.  
 
Indeed, if germ-line gene editing were to become widely used, the list of genes to be modified would 
most probably become longer and longer. Of course, as I have said, one could see some good in the 
use of germ-line gene editing in order to eliminate clear cases of burdensome genetic disease such 
as cystic fibrosis and thalassaemia. However, there is the fear that the technology could come to be 
used to overcome any kind of genetic trait viewed as a weakness or as an imperfection. And if this 
happened, the technique would in the end come to be used in the same spirit as genetic 
enhancement. Indeed, there is no sharp line between healing and enhancement. To use germ-line 
gene therapy to produce perfectly able and healthy children would mean fabricating babies that live 
up to certain standards of health perfection decided by parents or society. Effectively, going down 
the path of seeking to rid children of ever more and more bad genes is not very different from, but in 
reality it is the much the same as, making sure they have good genes, genes linked to physical traits 
and mental abilities deemed desirable by parents and society. There is no Rubicon separating germ-
line gene editing for therapeutic purposes from germ-line gene editing for the sake of enhancement. 
In other words, I am saying that while therapeutic use of germ-line gene editing might be welcomed, 
we should be aware of the risk of immoral use of germ-line gene editing in order to avoid any 
condition that might be viewed as a weakness.  So used the technology would be used for eugenic 
purposes.  
 
Today it is sometimes said that it is irresponsible to bring a Down syndrome child into the world. It is 
argued that children with Down syndrome pose a burden on families and on society. And it is 
pointed out that given the possibility of prenatal testing the birth of the child with this condition 
could have been avoided. Tomorrow failure to avail of germ-line gene editing therapy might similarly 
be denounced as irresponsible. This would reflect inherently eugenic attitudes.  And such attitudes 
are cause for concern inasmuch as they reflect discrimination and a failure to unconditionally accept 
and welcome the child. Fuelled by hubris, eugenics is blind to the giftedness of life. Accepting 
children as gifts means not treating embryos and foetuses as replaceable goods, goods to be 
discarded and replaced by better products if found imperfect. Accepting children as gifts means not 
                                                          
6CDF, Donum Vitae, 1987, Introduction. 1.  
making their welcome depend on whether they satisfy our demands for beauty, ability or perfect 
health.   
 
Eugenics, whatever form it takes, means usurping powers over the lives—and deaths--of others, 
while failing to recognize our creaturely limitations and the fact that true perfection is not of this 
world. Not content unconditionally to accept the child-to-be as a gift, it would seem that we are 
increasingly on a quest for the perfect child. But the attempt to create the perfect child, or the 
perfectly healthy child, is indeed an attempt to play God. As such it is an attempt at unreasonable 
domination over nature. Speaking in Christian terms, it represents a failure to recognize the image of 
God in each and every human being irrespective of his or her skills, looks or health. In sum, there is 
the risk that the use of germ-line gene editing could lead to regrettable parental and social attitudes 
and aspirations. It could lead to a society which is intolerant of difference and one in which one 
generation assumes undue powers over the next.    
 
Voicing his fears in his famous work The Abolition of Man,  C.S. Lewis wrote: ‘if any age attains, by 
eugenics and scientific education, the power to make its descendants what it pleases, all men who 
live after it are the patients of that power’.7 What he feared was the power of some humans to 
make future humans helpless products of their design.  
                                                          
7 S. Lewis, The Abolition of Man, in C.S. Lewis, The Abolition of Man (New York; HarperSanFrancisco, 2001), p. 
57. 
